Artwork

Content provided by The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

OUD Treatment and Intent To Treat Analysis

20:02
 
Share
 

Manage episode 276352129 series 2818069
Content provided by The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

X:BOT primary outcomes

We discuss the X:BOT primary outcomes paper in this episode of the podcast. Use the link above or the citation below to find it. Take a look at the figures!

JD Lee et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicenter, open-label, randomized controlled trial. Lancet 2018. 391:309-318.

X:BOT rationale and design paper

In this fascinating and thoughtful paper, the X:BOT authors discuss the study design choices they considered and how they selected various aspects of the trial design. A great read for those with interest in OUD treatment or clinical trials design.

X:BOT cost effectiveness analysis

This planned analysis of the X:BOT data provides an additional lens for determining which medication is the best option.

A great buprenorphine review

Thorough but brief review on the use of buprenorphine.

  continue reading

11 episodes

Artwork
iconShare
 
Manage episode 276352129 series 2818069
Content provided by The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The University of Texas Southwestern Medical Center - Adriane dela Cruz and Adriane dela Cruz or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

X:BOT primary outcomes

We discuss the X:BOT primary outcomes paper in this episode of the podcast. Use the link above or the citation below to find it. Take a look at the figures!

JD Lee et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicenter, open-label, randomized controlled trial. Lancet 2018. 391:309-318.

X:BOT rationale and design paper

In this fascinating and thoughtful paper, the X:BOT authors discuss the study design choices they considered and how they selected various aspects of the trial design. A great read for those with interest in OUD treatment or clinical trials design.

X:BOT cost effectiveness analysis

This planned analysis of the X:BOT data provides an additional lens for determining which medication is the best option.

A great buprenorphine review

Thorough but brief review on the use of buprenorphine.

  continue reading

11 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide